01 SANOFI SpA (3)
02 Sanofi-Aventis (Suisse) SA (4)
03 sanofi-aventis AB (2)
04 SUN PHARMACEUTICAL IND.EU.B.V. (3)
05 SUN Pharmaceutical Industries (1)
06 Sun Pharmaceutical - Netherlands (3)
07 ACCORD HEALTHCARE LIMITED (3)
08 AUROBINDO PHARMA ITALIA Srl (5)
09 Accord Healthcare Ltd. (1)
10 Actavis Group PTC ehf (3)
11 Actavis Group PTC ehf. (1)
12 Actavis Switzerland AG (2)
13 AqVida GmbH (4)
14 Deva Holding AS (2)
15 FRESENIUS KABI ONCOLOGY PLC (3)
16 Fresenius Kabi (Schweiz) AG (2)
17 Fresenius Kabi Oncology Plc (1)
18 GP PHARM (1)
19 HOSPIRA ITALIA Srl (3)
20 Hospira UK Limited (4)
21 MYLAN SpA (2)
22 Mylan Hospital AS (2)
23 SANDOZ GMBH (3)
24 SANDOZ SpA (4)
25 SEACROSS PHARMACEUTICALS (2)
26 Sandoz A/S, (1)
27 Sandoz Pharmaceuticals AG (2)
28 Stragen Pharma SA (4)
29 TEVA ITALIA Srl (3)
30 Teva Pharma AG (2)
31 Teva Sweden AB (1)
32 The Fresenius Kabi Oncology Plc (3)
33 medac Gesellschaft für (1)
01 Oxaliplatin (68)
02 oxaliplatin (13)
01 Concentrate to the infusion fluid, resolution (12)
02 INFUSION (2)
03 Infusion (12)
04 KONCENTRAT TILL INFUSIONSVÄTSKA, LÖSNING (10)
05 Oxaliplatino 100Mg 20Ml 1 Units Parenteral Use (11)
06 Oxaliplatino 150Mg 30Ml 1 Units Parenteral Use (2)
07 Oxaliplatino 200Mg 40Ml 1 Units Parenteral Use (8)
08 Oxaliplatino 50Mg 10Ml 1 Units Parenteral Use (11)
09 PULVER TILL INFUSIONSVÄTSKA, LÖSNING (3)
10 SOLUTION (2)
11 SOLUTION FOR INFUSION (4)
12 Soln. For Injection/Infusion (2)
13 Blank (2)
01 Germany (4)
02 Italy (32)
03 Norway (12)
04 Sweden (13)
05 Switzerland (16)
06 Turkey (2)
07 United Kingdom (2)
01 Eloxatin (5)
02 Oksaliplatin SUN (3)
03 Oxaliplatin Accord (1)
04 Oxaliplatin Actavis (4)
05 Oxaliplatin CSC (1)
06 Oxaliplatin Fresenius Kabi (1)
07 Oxaliplatin Hospira (4)
08 Oxaliplatin SUN (1)
09 Oxaliplatin Sandoz (1)
10 Oxaliplatin Teva (1)
11 Oxaliplatin The Fresenius Kabi (3)
12 Oxaliplatin medac (1)
13 Oxaliplatino (28)
14 Oxaliplatino Kabi (1)
15 Oxaplamyl (2)
16 Blank (24)